Good Pharma Scorecard
We rank companies on ethics and social responsibility performance criteria, focusing on issues that are critical to patients and public health.
We rank companies on ethics and social responsibility performance criteria, focusing on issues that are critical to patients and public health.
The Good Pharma Scorecard ranks companies on their bioethics and social responsibility performance, taking into account ethics and legal standards. Measures evaluate the integrity of clinical trial designs, the accessibility of medicines, marketing practices, diversity and fair inclusion, among other ethics and human rights issues. Below is a sample of our transparency and data sharing rankings.
Transparency in research and marketing help protect and respect trial participants and medicine and vaccine consumers
Sound marketing practices and evidenced based medicine require product safety and efficacy data be in the public domain
Being able to learn from what other scientists have already done- both accomplishments and failures- stimulates innovation and ultimately the delivery of lifesaving products.
Transparency is key to maximizing the value of trial data and people’s participation in research
Opacity can drive up costs of research and care
Transparency and data-sharing enable validation and replication of study findings
AbbVie
Amgen
Bayer
Novartis
Merck
Novo Nordisk
Sanofi / Genzyme
Johnson & Johnson / Janssen
Gilead
AstraZeneca
Pfizer
Celgene
Median: 73%
Valeant
Company ranking
higher than last ranking
Company ranking
lower than last ranking
Company ranking
unchanged from last ranking